The human papillomavirus E6 and E7 inducible oncogene, hWAPL, exhibits potential as a therapeutic target
2005
hWAPL as a Target for Cervical Cancer Therapy
Sample size: 8
publication
Evidence: moderate
Author Information
Author(s): Kuroda M, Kiyono T, Oikawa K, Yoshida K, Mukai K
Primary Institution: Tokyo Medical University
Hypothesis
HPV E6 and E7 oncoproteins induce hWAPL expression, which may be targeted for cervical cancer therapy.
Conclusion
hWAPL may be an effective therapeutic target for treating cervical cancer, as its suppression inhibits tumor growth.
Supporting Evidence
- HPV E6 and E7 oncoproteins induce hWAPL expression.
- siRNA targeting hWAPL suppressed tumor growth in mice.
- Repression of hWAPL expression inhibited cell growth in cervical cancer-derived cells.
Takeaway
Scientists found that a gene called hWAPL helps cervical cancer grow, and by turning it off, they can make the cancer shrink.
Methodology
The study involved cell culture, retroviral infection, and tumor growth analysis in nude mice.
Limitations
The effects of siRNA were not always preserved, indicating potential challenges for clinical application.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website